Targetable mutations in gastrointestinal malignancies: A comparison of RAS mutant and RAS wild type tumors.

129Background: KRAS and NRAS (RAS) mutations are considered driver mutations in gastrointestinal malignancies such as colorectal and pancreatic cancer. Our institution obtains broad molecular testi...